Click here to close now.




















Welcome!

News Feed Item

Epilepsy Foundation Presents Lifetime Accelerator Award to H. Steven White, Ph.D., for Contributions to the Field of Epilepsy and Seizures

Dr. White to Be Honored at 4th Biennial Epilepsy Pipeline Conference 2014 in San Francisco June 5-7

LANDOVER, MD--(Marketwired - May 29, 2014) - The Epilepsy Foundation announced today that H. Steven White, Ph.D., professor of pharmacology and toxicology and principal investigator of the National Institutes of Health (NIH)-sponsored Anticonvulsant Drug Development Program at the University of Utah College of Pharmacy, has been named the 2014 recipient of the Epilepsy Foundation's Lifetime Accelerator Award, in recognition of his commitment and pioneering contributions to the field of epilepsy and seizures. Dr. White will be honored at the 4th Biennial Epilepsy Pipeline Conference 2014, being held June 5-7, 2014, at the Hyatt Regency San Francisco.

A leader in translational research in anticonvulsant drug therapies, Dr. White is well-recognized for his scientific leadership of the University of Utah NIH-sponsored Anticonvulsant Drug Development (ADD) Program, founded in 1975 by the late Ewart A. Swinyard in collaboration with the National Institutes of Neurological Disorders and Stroke (NINDS), NIH. Dr. White's career in antiepileptic drug discovery began in 1986 as the senior scientist of the ADD Program. Over the three decades that mark Dr. White's research in the field, this program has played a crucial role in the early identification and characterization of thousands of novel anticonvulsant medications using established seizure and epilepsy models. Dr. White's laboratory has identified and characterized the anticonvulsant profile and potential mechanism of action for established and new anti-epilepsy agents. Notably, the efforts of the faculty, staff and students of this program, which Dr. White has directed since 2001, have since its establishment in 1975 contributed to the successful development of multiple new therapeutics, including felbamate, rufinamide, topiramate, retigabine and lacosamide.

"On behalf of the Epilepsy Foundation and many clinicians treating seizure conditions today, we are especially pleased to honor Dr. White with the Lifetime Accelerator Award and to recognize his outstanding contributions in anticonvulsant drug development," said Philip M. Gattone, president and CEO of the Epilepsy Foundation. "We are grateful not only for his steadfast commitment to our mission, but also for his energy and enthusiasm for mentoring the next generation of neuroscientists and epilepsy educators."

"Dr. White has been a force behind many of the therapeutics used in treatment today. He is truly dedicated to finding therapies that will make a difference to patients through development of new animal models," said Jacqueline A. French, M.D., director of the Epilepsy Study Consortium, and director of clinical trials at NYU's Comprehensive Epilepsy Center. "He has given generously of his free time to collaborate with other researchers and epilepsy organizations and this recognition is well-deserved."

Ongoing translational research in Dr. White's laboratory is focused on the development of novel models of therapy resistant models and understanding the influence of genetics on the pathophysiology, seizure-susceptibility and anti-epileptic drug pharmacology of animal seizure and epilepsy models. Dr. White and his colleagues at Utah and the NINDS are conducting research that may lead to novel therapies for treatment-resistant epilepsy and importantly, disease-modifying therapies with the potential to halt, slow, or prevent the development of epilepsy in susceptible individuals. He is also a scientific co-founder of NeuroAdjuvants, Inc., a Salt Lake City-based biotechnology firm focused on the development of metabolically stable, blood-brain-barrier neuropeptides for the treatment of refractory epilepsy and pain.

Dr. White earned his Ph.D. in Pharmacology in 1984 at the University of Utah and an M.S. in Pharmacology and baccalaureate degree in Pharmacy at Idaho State University. He began his career as a practicing pharmacist and since 1984 has risen through the academic ranks at the University of Utah. On November 18, 2011, Dr. White received an Honorary Doctor of Science from The University of Copenhagen Faculty of Pharmaceutical Sciences, Copenhagen, Denmark. Over the years, Dr. White has been the recipient of significant research funding from the National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), and he and his collaborators have published over 170 original papers pertaining to the mechanism of action and the pharmacology of antiepileptic drugs. In addition to his academic service, Dr. White has served as Research Director of CURE (Citizen's United for Research in Epilepsy), the largest non-governmental provider of epilepsy research funding, since November 2011.

Epilepsy Foundation's Lifetime Accelerator Award
The Lifetime Accelerator Award was established in 2012 to honor physicians, scientists, industry leaders, and other individuals who have demonstrated a lifelong commitment to bringing new therapies to people living with epilepsy. Lifetime Accelerator Award recipients are chosen by an independent committee of global thought leaders and clinical investigators in epilepsy and seizure therapy discovery and development. Harvey Kupferberg, Ph.D., past chief of the Preclinical Pharmacology Section, Epilepsy Branch, NINDS, NIH, was conferred the 2012 Lifetime Accelerator Award, and Henrik Klitgaard, Ph.D., vice president, head CNS research, UCB, received the award in 2013. 

About Epilepsy
When a person has two or more unprovoked seizures, they have epilepsy, which affects more than 2 million people in the United States and 65 million people worldwide. This year, another 150,000 people in our country will be diagnosed with epilepsy. Despite all available treatments, four out of 10 people with epilepsy continue to experience uncontrolled seizures while many more experience less than optimal seizure control.

About the Epilepsy Foundation
The Epilepsy Foundation, a national non-profit with 48 affiliated organizations throughout the United States, has led the fight against seizures since 1968. The Foundation is an unwavering ally for individuals and families impacted by epilepsy and seizures. The mission of the Epilepsy Foundation is to stop seizures and sudden unexpected death in epilepsy (SUDEP), find a cure and overcome the challenges created by epilepsy through efforts including education, advocacy and research to accelerate ideas into therapies. The Foundation works to ensure that people with seizures have the opportunity to live their lives to their fullest potential. For additional information, please visit www.epilepsy.com.

"Like" the Epilepsy Foundation on Facebook at www.facebook.com/epilepsyfoundationofamerica and follow us on Twitter at www.twitter.com/epilepsyfdn

The following files are available for download:

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Latest Stories
The Internet of Things is in the early stages of mainstream deployment but it promises to unlock value and rapidly transform how organizations manage, operationalize, and monetize their assets. IoT is a complex structure of hardware, sensors, applications, analytics and devices that need to be able to communicate geographically and across all functions. Once the data is collected from numerous endpoints, the challenge then becomes converting it into actionable insight.
SYS-CON Events announced today that IceWarp will exhibit at the 17th International Cloud Expo®, which will take place on November 3–5, 2015, at the Santa Clara Convention Center in Santa Clara, CA. IceWarp, the leader of cloud and on-premise messaging, delivers secured email, chat, documents, conferencing and collaboration to today's mobile workforce, all in one unified interface
SYS-CON Events announced today that Micron Technology, Inc., a global leader in advanced semiconductor systems, will exhibit at the 17th International Cloud Expo®, which will take place on November 3–5, 2015, at the Santa Clara Convention Center in Santa Clara, CA. Micron’s broad portfolio of high-performance memory technologies – including DRAM, NAND and NOR Flash – is the basis for solid state drives, modules, multichip packages and other system solutions. Backed by more than 35 years of tech...
With the Apple Watch making its way onto wrists all over the world, it’s only a matter of time before it becomes a staple in the workplace. In fact, Forrester reported that 68 percent of technology and business decision-makers characterize wearables as a top priority for 2015. Recognizing their business value early on, FinancialForce.com was the first to bring ERP to wearables, helping streamline communication across front and back office functions. In his session at @ThingsExpo, Kevin Roberts...
U.S. companies are desperately trying to recruit and hire skilled software engineers and developers, but there is simply not enough quality talent to go around. Tiempo Development is a nearshore software development company. Our headquarters are in AZ, but we are a pioneer and leader in outsourcing to Mexico, based on our three software development centers there. We have a proven process and we are experts at providing our customers with powerful solutions. We transform ideas into reality.
As more and more data is generated from a variety of connected devices, the need to get insights from this data and predict future behavior and trends is increasingly essential for businesses. Real-time stream processing is needed in a variety of different industries such as Manufacturing, Oil and Gas, Automobile, Finance, Online Retail, Smart Grids, and Healthcare. Azure Stream Analytics is a fully managed distributed stream computation service that provides low latency, scalable processing of ...
In 2014, the market witnessed a massive migration to the cloud as enterprises finally overcame their fears of the cloud’s viability, security, etc. Over the past 18 months, AWS, Google and Microsoft have waged an ongoing battle through a wave of price cuts and new features. For IT executives, sorting through all the noise to make the best cloud investment decisions has become daunting. Enterprises can and are moving away from a "one size fits all" cloud approach. The new competitive field has ...
SYS-CON Events announced today the Containers & Microservices Bootcamp, being held November 3-4, 2015, in conjunction with 17th Cloud Expo, @ThingsExpo, and @DevOpsSummit at the Santa Clara Convention Center in Santa Clara, CA. This is your chance to get started with the latest technology in the industry. Combined with real-world scenarios and use cases, the Containers and Microservices Bootcamp, led by Janakiram MSV, a Microsoft Regional Director, will include presentations as well as hands-on...
17th Cloud Expo, taking place Nov 3-5, 2015, at the Santa Clara Convention Center in Santa Clara, CA, will feature technical sessions from a rock star conference faculty and the leading industry players in the world. Cloud computing is now being embraced by a majority of enterprises of all sizes. Yesterday's debate about public vs. private has transformed into the reality of hybrid cloud: a recent survey shows that 74% of enterprises have a hybrid cloud strategy. Meanwhile, 94% of enterprises ar...
Everyone talks about continuous integration and continuous delivery but those are just two ends of the pipeline. In the middle of DevOps is continuous testing (CT), and many organizations are struggling to implement continuous testing effectively. After all, without continuous testing there is no delivery. And Lab-As-A-Service (LaaS) enhances the CT with dynamic on-demand self-serve test topologies. CT together with LAAS make a powerful combination that perfectly serves complex software developm...
SYS-CON Events announced today that the "Second Containers & Microservices Expo" will take place November 3-5, 2015, at the Santa Clara Convention Center in Santa Clara, CA. Containers and microservices have become topics of intense interest throughout the cloud developer and enterprise IT communities.
Moving an existing on-premise infrastructure into the cloud can be a complex and daunting proposition. It is critical to understand the benefits as well as the challenges associated with either a full or hybrid approach. In his session at 17th Cloud Expo, Richard Weiss, Principal Consultant at Pythian, will present a roadmap that can be leveraged by any organization to plan, analyze, evaluate and execute on a cloud migration solution. He will review the five major cloud transformation phases a...
Mobile, social, Big Data, and cloud have fundamentally changed the way we live. “Anytime, anywhere” access to data and information is no longer a luxury; it’s a requirement, in both our personal and professional lives. For IT organizations, this means pressure has never been greater to deliver meaningful services to the business and customers.
WebRTC services have already permeated corporate communications in the form of videoconferencing solutions. However, WebRTC has the potential of going beyond and catalyzing a new class of services providing more than calls with capabilities such as mass-scale real-time media broadcasting, enriched and augmented video, person-to-machine and machine-to-machine communications. In his session at @ThingsExpo, Luis Lopez, CEO of Kurento, will introduce the technologies required for implementing thes...
eCube Systems has released NXTmonitor, a full featured application orchestration solution. NXTmonitor, which inherited the code base of NXTminder, has been extended to support multi-discipline processes and will act as a DevOps utility in a heterogeneous enterprise environment. Previously, NXTminder was packaged with NXTera middleware to configure and manage Entera and NXTera RPC servers. “Since we are widening the focus of this solution to DevOps, we felt the need to change the name to NXTmon...